Results 61 to 70 of about 4,959 (174)

Thyroid-stimulating immunoglobulins as measured in a reporter bioassay are not detected in patients with Hashimoto’s thyroiditis and ophthalmopathy or isolated upper eyelid retraction

Clinical Ophthalmology, 2014
Jack R Wall,1 Hooshang Lahooti,1 Ilhem El Kochairi,1 Simon D Lytton,2 Bernard Champion1 1Department of Medicine, the University of Sydney, Penrith, NSW, Australia; 2SeraDiaLogistics, Munich, Germany Abstract: Although ophthalmopathy is mainly ...
Wall JR, Lahooti H, El Kochairi I, Lytton SD, Champion B   +4 more
doaj  

Does autoimmunity against thyroglobulin play a role in the pathogenesis of Graves’ ophthalmopathy: a review

Clinical Ophthalmology, 2015
Thayalini Shanmuganathan,1 Christian Girgis,2 Hooshang Lahooti,1 Bernard Champion,1 Jack R Wall1 1Department of Medicine, Nepean Clinical School, Nepean Hospital, The University of Sydney, Sydney, 2Department of Medicine, Westmead Millennium Institute ...
Shanmuganathan T, Girgis C, Lahooti H, Champion B, Wall JR   +4 more
doaj  

Pathogenesis of Graves’ Ophthalmopathy [PDF]

International Archives of Allergy and Immunology, 2009
C, Spitzweg, A E, Heufelder
openaire   +2 more sources

The relationship between Graves’ ophthalmopathy and dry eye syndrome

Clinical Ophthalmology, 2014
Jessica H Selter,1 Anisa I Gire,2 Shameema Sikder2 1Johns Hopkins School of Medicine, 2Wilmer Ophthalmological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA Background: A complex relationship between Graves&rsquo ...
Selter JH, Gire AI, Sikder S
doaj  

An Appraisal of the Preventive Effect of Statins on the Development of Graves’ Ophthalmopathy: A Hospital-Based Cohort Study

Ophthalmology and Therapy
Introduction Graves’ ophthalmopathy (GO) is an autoimmune inflammatory disorder observed in a substantial proportion of patients with Graves’ disease (GD), with debilitating symptoms of disfiguring, periorbital pain, dry eyes, diplopia, and even visual ...
Grace Chia-Yen Hsu, Shyang-Rong Shih, Fang-Yu Chang, Shu-Lang Liao, Yi-Hsuan Wei   +4 more
doaj   +1 more source

Prevalence of Graves ophthalmopathy among patients with thyroid disease

Philippine Journal of Ophthalmology, 2010
Objective: This study determined the prevalence of Graves ophthalmopathy among thyroid-disease patients at a tertiary government hospital. Methods: Patients with thyroid disease seen at a tertiary hospital from February to September 2007 were enrolled.
Erwin D. Palisoc, MD, Evelyn S. Morabe, MD, Paulo Ma. N. Pagkatipunan, MD   +2 more
doaj  

Long-term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity: heterogeneity of autoimmune ophthalmopathy

Clinical Ophthalmology, 2012
Tom McCorquodale,1 Hooshang Lahooti,1 Bamini Gopinath,2 Jack R Wall11Department of Medicine, Nepean Clinical School, the University of Sydney, Penrith, NSW, Australia; 2Centre for Vision Research, the University of Sydney, Westmead Hospital, Westmead ...
McCorquodale T, Lahooti H, Gopinath B, Wall JR   +3 more
doaj  

Graves' ophthalmopathy

Swiss Medical Weekly, 2002
Swiss Medical Weekly
doaj   +1 more source

Steroid Treatment Focused Management of Graves’ Ophthalmopathy

Acta Medica Bulgarica
Graves' disease (GD) is an autoimmune disease that affects the thyroid and the eyes. Graves' ophthalmopathy (GO), an autoimmune disease, usually appears 18 months after GD diagnosis.
Condeng Y. H., Umar H., Aman A. M., Rasyid H., Bakri S., Iskandar H.   +5 more
doaj   +1 more source

Update on the medical treatment of Graves’ ophthalmopathy

International Journal of General Medicine, 2009
Gregory J Griepentrog, James A GarrityDepartment of Ophthalmology, Mayo Clinic, Rochester, MN, USAPurpose: To review recent advances in the understanding of Graves’ ophthalmopathy (GO) pathogenesis as well as discuss current and future medical ...
Gregory J Griepentrog, James A Garrity
doaj